ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1023

Neutrophils Are an Important Source of Microparticles in Lupus and Asymptomatic ANA+ Individuals

Carolina Muñoz-Grajales1, Dennisse Bonilla 2, Earl D. Silverman 3, Sindhu Johnson 4, Arthur Bookman 5, Zahi Touma 2, Zareen Ahmad 6, Linda Hiraki 7 and Joan Wither 8, 1University of Toronto, Toronto, Canada, 2University Health Network, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 4Toronto Scleroderma Program, Department of Medicine, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Canada, Toronto, Canada, 5University Health Network - Toronto Western Hospital, Toronto, Canada, 6Mount Sinai Hospital, Toronto, Canada, 7The Hospital for Sick Children, Toronto, Canada, 8University Health Network, Krembil Research Institute, Toronto, ON, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Antinuclear antibodies (ANA), microparticles and neutrophils, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Apoptotic microparticles (MPs) in the circulation of systemic lupus erythematosus (SLE) patients are enriched for nucleic acids and complexed with IgG (MP-IC), as compared with those from healthy controls (HC).  These MPs have been shown to activate monocytes, suggesting that they are an important stimulus for production of pro-inflammatory factors in SLE. We previously presented data showing that nucleic acid-enriched IgG-complexed MPs are also increased in asymptomatic anti-nuclear antibody (ANA) positive individuals (ANA+NS), in the absence of elevated levels of pro-inflammatory factors. Although platelets represent the main source of MPs in healthy individuals, endothelial- and neutrophil-derived MPs are also found in SLE. In this study, we examined the origin of MPs in ANA+NS.

Methods: Flow cytometry was used to examine the number, origin, nucleic acid content, and IgG binding of peripheral blood Annexin V+MPs in ANA–HC (n=18), ANA+NS (≥1:160 by IF, n=48), and SLE patients (n=33). MP nucleic acid content was determined by staining with Syto13 and the MP cell source by staining with antibodies against CD41a (Platelets), CD105 (endothelium), CD45 (hematopoietic cells), CD14 (monocytes), CD66b (neutrophils), CD19 (B cells), CD3 (T cells), and CD235a (erythrocytes).

Results: Consistent with published work and with our previous data, SLE patients had increased levels of MPs and MP-ICs that contained higher levels of nucleic acids, as compared to ANA– HC. A subset of ANA+NS had similar elevations in the amount of IgG coating their MPs and nucleic acid content to those seen in SLE. As expected, the majority of the MPs obtained from HC exhibited platelet markers (Figure A). Notably, in ANA+NS individuals and SLE patients the proportion of Annexin V+ platelet-MPs was reduced compared to HC (Figure A) and there were increased proportions of Annexin V+ CD66b+MPs (apoptotic neutrophils-MPs) and CD45+MPs (hematopoietic) (Figure B and C). However, the proportion of neutrophil-MPs was significantly higher in SLE than in ANA+NS (Figure B). There were non-statistically significant trends to higher CD14+MPs (monocytes-MPs) and endothelial MPs in ANA+ NS. There were no CD19, CD3, or CD235a positive MPs detected.  

Conclusion: Apoptotic and/or activated neutrophils and hematopoietic cells are a significant source of auto-antigenic MPs in both ANA+NS individuals and SLE patients.  However, neutrophil apoptosis/activation appears to be more prominent in SLE patients, raising the possibility that it contributes to the pro-inflammatory process that discriminates symptomatic and asymptomatic ANA+individuals.


Figure ACR 2019


Disclosure: C. Muñoz-Grajales, None; D. Bonilla, None; E. Silverman, None; S. Johnson, Bayer, 2, Boehringer Ingelheim, 2, 5, Corbus, 2, Ikaria, 5, Roche, 2; A. Bookman, None; Z. Touma, Janssen Research & Development, LLC, 2, Janssen Scientific Affairs, LLC, 2; Z. Ahmad, None; L. Hiraki, None; J. Wither, None.

To cite this abstract in AMA style:

Muñoz-Grajales C, Bonilla D, Silverman E, Johnson S, Bookman A, Touma Z, Ahmad Z, Hiraki L, Wither J. Neutrophils Are an Important Source of Microparticles in Lupus and Asymptomatic ANA+ Individuals [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/neutrophils-are-an-important-source-of-microparticles-in-lupus-and-asymptomatic-ana-individuals/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophils-are-an-important-source-of-microparticles-in-lupus-and-asymptomatic-ana-individuals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology